BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 29968540)

  • 21. Discovery of pyrimidine-tethered benzothiazole derivatives as novel anti-tubercular agents towards multi- and extensively drug resistant
    Hemeda LR; El Hassab MA; Abdelgawad MA; Khaleel EF; Abdel-Aziz MM; Binjubair FA; Al-Rashood ST; Eldehna WM; El-Ashrey MK
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2250575. PubMed ID: 37649381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of novel N' (4-aryloxybenzylidene)- 1H-benzimidazole-2 carbohydrazide derivatives as anti-tubercular agents.
    Siddiki AA; Bairwa VK; Telvekar VN
    Comb Chem High Throughput Screen; 2014; 17(7):630-8. PubMed ID: 24625232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quinoline derivatives as potential anti-tubercular agents: Synthesis, molecular docking and mechanism of action.
    Liu CX; Zhao X; Wang L; Yang ZC
    Microb Pathog; 2022 Apr; 165():105507. PubMed ID: 35354076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and antitubercular screening of some novel 4H-1,4- benzothiazines and their sulfones under environment benign solvent free conditions as future anti-tubercular agents.
    Guleria A; Jangid DK; Gautam N; Lakhotia R; Chowdhary A; Gautam DC
    Comb Chem High Throughput Screen; 2015; 18(1):48-52. PubMed ID: 25426761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and Antibacterial Activity of Mefloquine-Based Analogs Against Sensitive and Resistant Mycobacterium tuberculosis Strains.
    da Silva Araújo A; Moraes AM; Lourenço MCS; Pessoa CO; da Silva ET; de Souza MVN
    Curr Top Med Chem; 2019; 19(9):683-689. PubMed ID: 30836914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances of pyrazole-containing derivatives as anti-tubercular agents.
    Xu Z; Gao C; Ren QC; Song XF; Feng LS; Lv ZS
    Eur J Med Chem; 2017 Oct; 139():429-440. PubMed ID: 28818767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent developments of coumarin-containing derivatives and their anti-tubercular activity.
    Hu YQ; Xu Z; Zhang S; Wu X; Ding JW; Lv ZS; Feng LS
    Eur J Med Chem; 2017 Aug; 136():122-130. PubMed ID: 28494250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyridine and nitro-phenyl linked 1,3,4-thiadiazoles as MDR-TB inhibitors.
    Patel H; Jadhav H; Ansari I; Pawara R; Surana S
    Eur J Med Chem; 2019 Apr; 167():1-9. PubMed ID: 30743094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of anti-tubercular activity of Schiff bases of 2-Amino thiazoles.
    Cordeiro R; Kachroo M
    Bioorg Med Chem Lett; 2020 Dec; 30(24):127655. PubMed ID: 33130292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and Structure-Activity relationship of 1-(5-isoquinolinesulfonyl)piperazine analogues as inhibitors of Mycobacterium tuberculosis IMPDH.
    Singh V; Pacitto A; Donini S; Ferraris DM; Boros S; Illyés E; Szokol B; Rizzi M; Blundell TL; Ascher DB; Pato J; Mizrahi V
    Eur J Med Chem; 2019 Jul; 174():309-329. PubMed ID: 31055147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
    Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
    Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents.
    Shiva Raju K; AnkiReddy S; Sabitha G; Siva Krishna V; Sriram D; Bharathi Reddy K; Rao Sagurthi S
    Bioorg Med Chem Lett; 2019 Jan; 29(2):284-290. PubMed ID: 30497913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel 1-(4-substituted benzylidene)-4-(1-(substituted methyl)-2,3-dioxoindolin-5-yl)semicarbazide derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) and MDR-TB strain.
    Raja S; Prakash CR
    Arch Pharm Res; 2013 Apr; 36(4):411-22. PubMed ID: 23440582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as anti-tubercular agents.
    Jadhavar PS; Dhameliya TM; Vaja MD; Kumar D; Sridevi JP; Yogeeswari P; Sriram D; Chakraborti AK
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2663-9. PubMed ID: 27095514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 4-Aryl-1,4-Dihydropyridines as Potential Enoyl-Acyl Carrier Protein Reductase Inhibitors: Antitubercular Activity and Molecular Docking Study.
    Venugopala KN; Deb PK; Pillay M; Chopra D; Chandrashekharappa S; Morsy MA; Aldhubiab BE; Attimarad M; Nair AB; Sreeharsha N; Kandeel M; Venugopala R; Mohanlall V
    Curr Top Med Chem; 2021; 21(4):295-306. PubMed ID: 33138763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antitubercular activity of 2-(substituted phenyl/benzyl-amino)-6-(4-chlorophenyl)-5-(methoxycarbonyl)-4-methyl-3,6-dihydropyrimidin-1-ium chlorides.
    Narayanaswamy VK; Nayak SK; Pillay M; Prasanna R; Coovadia YM; Odhav B
    Chem Biol Drug Des; 2013 Feb; 81(2):219-27. PubMed ID: 23150983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach.
    Uddin R; Zahra NU; Azam SS
    Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents.
    Penta A; Franzblau S; Wan B; Murugesan S
    Eur J Med Chem; 2015 Nov; 105():238-44. PubMed ID: 26498570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and characterization of (1-(4-aryl)- 1H-1,2,3-triazol-4-yl)methyl, substituted phenyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates against Mycobacterium tuberculosis.
    Venugopala KN; Dharma Rao GB; Bhandary S; Pillay M; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K
    Drug Des Devel Ther; 2016; 10():2681-90. PubMed ID: 27601885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances of imidazole-containing derivatives as anti-tubercular agents.
    Fan YL; Jin XH; Huang ZP; Yu HF; Zeng ZG; Gao T; Feng LS
    Eur J Med Chem; 2018 Apr; 150():347-365. PubMed ID: 29544148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.